Doctors track side effects of liver cancer drug in Real-World patients
NCT ID NCT05100082
Summary
This study monitored the safety of the cancer drug Cabometyx (cabozantinib) in 263 Japanese patients with advanced liver cancer that could not be removed by surgery. The main goal was to check for side effects and serious health problems over 12 months of treatment. Doctors also tracked how the cancer responded to the drug and how long patients lived.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Takeda Selected Site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.